Advances in genomic and pharmacokinetic profiling for clinical stratification of metastatic breast cancer
{{output}}
Background: Metastatic breast cancer (MBC) is the most significant clinical challenge in patient care; hence, we need new personalized therapeutic targets and innovative inhibitors. Genomic, proteomic, and structural analysis can... ...
